ask="90.20"
ask_size="100"
average_daily_volume="547382"
bid="55.00"
bid_size="10000"
book_value="11.38"
change="-0.12"
change_from_200_day_moving_average="4.67"
change_from_50_day_moving_average="2.04"
change_from_52_week_high="-12.78"
change_From_52_week_low="27.47"
change_in_percent="-0.16%"
close="73.99"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="74.48"
high_52_weeks="86.77"
last_trade_date="2/6/2017"
last_trade_price="73.99"
last_trade_size="9598"
last_trade_time="4:00pm"
low="72.60"
low_52_weeks="46.52"
market_capitalization="3.02B"
moving_average_200_day="69.32"
moving_average_50_day="71.95"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="73.89"
pe_ratio="N/A"
peg_ratio="-0.41"
percent_change_from_200_day_moving_average="+6.73%"
percent_change_from_50_day_moving_average="+2.84%"
percent_change_from_52_week_high="-14.73%"
percent_change_from_52_week_low="+59.05%"
previous_close="74.11"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.51"
price_per_sales="23656.72"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="12.30"
stock_exchange="NMS"
symbol="RARE"
volume="397826"
weeks_range_52="46.52 - 86.77"
